S3 E16 | How China Disrupted Global Pharma | Biotech Licensing, Fast Clinical Trials, and the R&D Gold Rush Ft. Dr. Julien Willard | 21 Min Pharma Edge Powered by Game of Pharma

S3 E17 | The Billion-Dollar GLP-1 Boom | Why GLP-1s Are Changing Pharma Forever (And How Brands Must Adapt) Ft. Dr. Evan Nadler | 21 Min Pharma Edge Powered by Game of Pharma

The obesity market is experiencing the most explosive growth in modern pharmaceutical history. With the rise of GLP-1 medications and a flood of semaglutide generics entering the market, the landscape is shifting from clinical discovery to a massive battle for market access and positioning. In this episode of Game of Pharma, Lokesh sits down with Dr. Evan Nadler to decode the reality of this multi-billion-dollar therapeutic gold rush. We move past the consumer hype and break down the commercial realities of metabolic treatments. In this episode, we cover: * The GLP-1 Gold Rush: How the massive surge in obesity therapeutics is fundamentally changing pharmaceutical brand strategy. * The Access Gap: Why the gap in treatment access is the single biggest opportunity (and hurdle) in healthcare right now. * US vs. India: Comparing the structural differences between the US and Indian markets regarding metabolic therapies. * Semaglutide Positioning: How pharma companies must position their branded generics to win the long game in a highly saturated market. Whether you are a pharma marketer, brand manager, or healthcare executive, this conversation provides a strategic roadmap for navigating the biggest market shift in a generation. #PharmaStrategy #GLP1 #ObesityMarket #PharmaMarketing #HealthcareInnovation #GameOfPharma #Semaglutide #BestPharmaPodcast Dr. Nadler's LinkedIn: https://www.linkedin.com/in/evanpnadler/ [https://www.linkedin.com/in/evanpnadler/] Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/ [https://www.linkedin.com/in/lokesh-sharma-7250a71a9/] Follow us on social media- Website: https://gameofpharma.com/ [https://gameofpharma.com/] Instagram: https://www.instagram.com/gameofpharma/ [https://www.instagram.com/gameofpharma/] LinkedIn: https://www.linkedin.com/company/game-of-pharma/ [https://www.linkedin.com/company/game-of-pharma/]

S3 E16 | How China Disrupted Global Pharma | Biotech Licensing, Fast Clinical Trials, and the R&D Gold Rush Ft. Dr. Julien Willard | 21 Min Pharma Edge Powered by Game of Pharma

Most people still think of China as just a generics producer. They are dead wrong. In just one decade, China has transformed from "copycat" to cutting-edge, and now Big Pharma is licensing assets from China, not just to it. In this episode of Game of Pharma, Lokesh sits down with Dr. Julien Willard, former senior intelligence officer, health economist, and strategy executive at Accenture and IBM, to decode what is really happening in global biotech. In this episode, we cover: * The Big Shift: The single biggest sign China's pharma industry has fundamentally changed. * The Gold Rush: Why global pharmaceutical companies are scrambling for Chinese biotech assets. * Speed to Market: How clinical trials that take years in the West are being executed in months in Shanghai. * The US vs. China: What Western pharma should (and absolutely shouldn't) copy from China's aggressive playbook. If you make decisions in pharma, biotech, healthcare strategy, or investment, this conversation will change how you see the next decade of the industry. #PharmaStrategy #BiotechTrends #ClinicalTrials #HealthcareInvestment #PharmaMarketing #DrugDevelopment #Pharma #Biotech #Pharmaceuticals #LifeSciences #HealthcareInnovation Julien's LinkedIn: https://www.linkedin.com/in/julienwillard/ [https://www.linkedin.com/in/julienwillard/] Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/ [https://www.linkedin.com/in/lokesh-sharma-7250a71a9/] Follow us on social media- Website: https://gameofpharma.com/ [https://gameofpharma.com/] Instagram: https://www.instagram.com/gameofpharma/ [https://www.instagram.com/gameofpharma/] LinkedIn: https://www.linkedin.com/company/game-of-pharma/ [https://www.linkedin.com/company/game-of-pharma/]

S3 E15 | Unlocking Wearable Data for Pharma | How ROOK's API is Transforming Clinical Trials Ft. Marco Benitez | 21 Min Pharma Edge Powered by Game of Pharma

The future of clinical trials and pharmacovigilance relies heavily on patient data, but integrating that data is a massive challenge. With countless touchpoints and messy data formats across different devices, how can the pharmaceutical industry actually make sense of it all? In this episode of Game of Pharma, Lokesh sits down with Marco Benitez, the CEO and founder of ROOK. Marco brings a wealth of experience to the table, having previously served as the Head of Medical Affairs at Roche before founding his tech company. We dive deep into how ROOK is solving the healthcare industry's fragmented data problem. In this episode, we cover: * The ROOK API Solution: How ROOK integrates data from over 300 wearables—including Apple Watch, Polar, Garmin, and Huawei—into a single API platform. * Data Harmonization: The process of cleaning, standardizing, and harmonizing wearable data so that it is AI-ready for clinical trials and insurance companies. * The Big Pivot: How the pandemic forced ROOK to pivot from a fitness club hardware model (tracking heart rates on screens) into a massive B2B data science company. * Marco's Journey: Marco shares his incredible entrepreneurial path, starting from building a hospital algorithm at just 19 years old, to navigating Big Pharma, to pitching his multi-billion dollar data vision. * If you are working in clinical trials, healthcare tech, or digital strategy, this episode provides a clear roadmap on how unstructured wearable data is being transformed into actionable insights. #WearableTech #ClinicalTrials #DigitalHealth #PharmaInnovation #HealthData #GameOfPharma Marco's LinkedIn: https://www.linkedin.com/in/marcobzg/ [https://www.linkedin.com/in/marcobzg/] Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/ [https://www.linkedin.com/in/lokesh-sharma-7250a71a9/] Follow us on social media- Website: https://gameofpharma.com/ [https://gameofpharma.com/] Instagram: https://www.instagram.com/gameofpharma/ [https://www.instagram.com/gameofpharma/] LinkedIn: https://www.linkedin.com/company/game-of-pharma/ [https://www.linkedin.com/company/game-of-pharma/]

S3 • E14 | Why Most Pharma Brands Fail at Omnichannel (And How to Fix It) | Omnichannel Marketing in Pharma | Ft. Nick Smith - President - Loud Canvas Health & Former Digital Strategist Eversana | 21 Min Pharma Edge Powered by Game of Pharma

What does real omnichannel marketing look like in today’s pharma world? In this episode of Game of Pharma, we sit down with Nick Smith—Founder of Loud Canvas Health and ex-Eversana leader, to unpack what’s changed in pharma omnichannel, why personalization beats presence, and how behavior data can reshape brand strategy. Nick has worked on both niche and large-scale brands and shares powerful insights on: * Aligning brand goals with HCP and payer behavior * Creating omnichannel journeys that actually convert * Why rep visits are still gold (if tracked right) * Structuring websites for different stakeholders * Using omnichannel maturity models to future-proof brand plans * Whether you're in brand, marketing, or access strategy, this episode will challenge the way you think about omnichannel in pharma. Don’t forget to like, and hit the follow icon to stay updated with new episodes! #OmnichannelMarketing #PharmaMarketing #HealthcareStrategy #GameOfPharma #NickSmith #DigitalHealth #PatientCentric #HCPengagement #PayerStrategy #MarketingPodcast Nick's LinkedIn: https://www.linkedin.com/in/therealnicksmith/ [https://www.linkedin.com/in/therealnicksmith/] Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/ [https://www.linkedin.com/in/lokesh-sharma-7250a71a9/] Follow us on social media- Website: https://gameofpharma.com/ [https://gameofpharma.com/] Instagram: https://www.instagram.com/gameofpharma/ [https://www.instagram.com/gameofpharma/] LinkedIn: https://www.linkedin.com/company/game-of-pharma/ [https://www.linkedin.com/company/game-of-pharma/]

S3 • E13 | How Indian Pharmacies Are Going Digital | How Tech Is Changing Indian Pharmacies | Ft. Kaushal Shah - Founder PillO & eVitalRx | 21 Min Pharma Edge Powered by Game of Pharma

What if your medicines could be delivered faster than your pizza and by your trusted local pharmacist? In this episode of 21 Min Pharma Edge powered by Game of Pharma, we sit down with Kaushal Shah, the visionary behind eVitalRx and PillO, two startups that are redefining how India experiences pharmacy. From disrupting traditional retail chemists to building a digital backbone for pharmacies, Kaushal Shah walks us through his bold vision for the future. In this episode, we cover: The idea behind delivering medicines in under 60 minutes How PillO partners with local pharmacies to challenge the giants Balancing speed, safety, and trust in healthcare delivery If you're curious about the intersection of healthcare, tech, and Indian innovation — this one’s a must-watch. Don’t forget to like, comment, and subscribe for more episodes of Game of Pharma. Available on YouTube, Spotify, Gaana, JioSaavn, Amazon Music, and Apple Podcasts. #PharmaTech #eVitalRx #PillO #HealthcareInnovation #GameOfPharma #PharmacyStartup #QuickCommerce #HealthDelivery #IndianStartups #KaushalShah #21minpharmaedge #pharmapodcast #pharmacy #pharmacist Kaushal Shah's LinkedIn: https://www.linkedin.com/in/kaushalshah06/ [https://www.linkedin.com/in/kaushalshah06/] Host's LinkedIn: https://www.linkedin.com/in/lokesh-sharma-7250a71a9/ [https://www.linkedin.com/in/lokesh-sharma-7250a71a9/] Follow us on social media- Website: https://gameofpharma.com/ [https://gameofpharma.com/] Instagram: https://www.instagram.com/gameofpharma/ [https://www.instagram.com/gameofpharma/] LinkedIn: https://www.linkedin.com/company/game-of-pharma/ [https://www.linkedin.com/company/game-of-pharma/]